Intestinal microbiota interacts with other systems, especially the immune system, which is responsible for protecting the body by recognizing “stranger” (pathogen associated molecular patterns-PAMPs) and “danger” (damage-associated molecular patterns-DAMPs) molecular motifs. In this manner, it plays an important role in the pathogenesis of various diseases and health. Despite the use of probiotics that modulate the…
Biologics Template
Write in a clean editor, then format for Biologics in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Biologics format
Biologics is a peer-reviewed journal published by MDPI, covering SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, COVID-19 Clinical Research Studies. Over its lifetime it has published 152 papers, which have received 1,307 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Biologics 2023, 12, 45–58.
Formats any DOI in Biologics style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research Monoclonal and Polyclonal Antibodies Research COVID-19 Clinical Research Studies Biosimilars and Bioanalytical Methods Computational Drug Discovery Methods |
| ISSN | 2673-8449 |
| Citation impact (2-yr) | 2.02 |
| h-index | 19 |
| i10-index | 35 |
| Article processing charge | $1,082 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Federico II University Hospital |
| Journal website | www.mdpi.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Biologics per year
Citation impact of Biologics by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Biologics
Microbes are hardly seen as planktonic species and are most commonly found as biofilm communities in cases of chronic infections. Biofilms are regarded as a biological condition, where a large group of microorganisms gets adhered to a biotic or abiotic surface. In this context, Pseudomonas aeruginosa, a Gram-negative nosocomial pathogen is the main causative organism…
Coronavirus disease, COVID-19, has touched every country globally except five countries (North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective method to protect against infectious diseases. The objective is to ensure that everyone has access to a COVID-19 vaccine. The conventional vaccine development platforms are complex and time-consuming to obtain desired approved…
Therapeutic proteins treat many acute and chronic diseases that were until recently considered untreatable. However, their high development cost keeps them out of reach of most patients around the world. One plausible solution to lower-cost manufacturing is to adopt newer technologies like using Escherichia coli to express larger molecules, including full-length antibodies, generally relegated to…
Coronaviruses belong to the “Coronaviridae family”, which causes various diseases, from the common cold to SARS and MERS. The coronavirus is naturally prevalent in mammals and birds. So far, six human-transmitted coronaviruses have been discovered. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 in Wuhan, China. Common symptoms include fever,…